dalbavancin
Generic: dalbavancin
Labeler: teva pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
dalbavancin
Generic Name
dalbavancin
Labeler
teva pharmaceuticals, inc.
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Routes
Active Ingredients
dalbavancin hydrochloride 500 mg/25mL
Manufacturer
Identifiers & Regulatory
Product NDC
0480-3325
Product ID
0480-3325_7fddacee-2401-4514-acf0-3847da11c6e5
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA219465
Listing Expiration
2026-12-31
Marketing Start
2025-10-29
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
04803325
Hyphenated Format
0480-3325
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
dalbavancin (source: ndc)
Generic Name
dalbavancin (source: ndc)
Application Number
ANDA219465 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 500 mg/25mL
Packaging
- 1 VIAL in 1 CARTON (0480-3325-01) / 25 mL in 1 VIAL
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "7fddacee-2401-4514-acf0-3847da11c6e5", "openfda": {"unii": ["33WDQ7T81E"], "rxcui": ["1539243"], "spl_set_id": ["1f4a5924-96d7-445a-b75f-2c0e1ffd2dea"], "manufacturer_name": ["Teva Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0480-3325-01) / 25 mL in 1 VIAL", "package_ndc": "0480-3325-01", "marketing_start_date": "20251029"}], "brand_name": "Dalbavancin", "product_id": "0480-3325_7fddacee-2401-4514-acf0-3847da11c6e5", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Lipoglycopeptide Antibacterial [EPC]", "Lipoglycopeptides [CS]"], "product_ndc": "0480-3325", "generic_name": "Dalbavancin", "labeler_name": "Teva Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Dalbavancin", "active_ingredients": [{"name": "DALBAVANCIN HYDROCHLORIDE", "strength": "500 mg/25mL"}], "application_number": "ANDA219465", "marketing_category": "ANDA", "marketing_start_date": "20251029", "listing_expiration_date": "20261231"}